Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

BioNTech SE (BNTX)

NASDAQ
Symbol
Exchange
Currency
BNTXNASDAQUSD
BNTXNBIVAMXN
22UAyXetraEUR
22UAyFrankfurtEUR
22UAyTradeGateEUR
BNTXViennaEUR
Currency in USD
Disclaimer
86.71
-1.38(-1.57%)
Closed
Pre Market
87.51+0.80(+0.92%)

BNTX Comments

Denmark latest country to scrap all covid restriction, No more legal basis to have more restictions. I thikn next will be France - it is just impossible to quaratine 500k people a day - the economy will collapse. Also, vaccine demand is slowing, as half of the pouplation is infected and they will not need to (or cannot) get vaccinated. Most vaccinated to get a certificate, if you are infected you get a certificate for 180 days....so I see this slowing down to a flu vaccine volume.
Waiting for next breackout 157, hope it'll happend Today.
Just to tell you, coronavirus will never go away, it is a known fact from the poultry industry, all the chicks are vaccinated...
bounced off the lt uptrend line and horizontal support, possible target is the gap fill at ~195, also needs to avoid a possible h&s on trend break https://invst.ly/x7te7
if tomorrow is also green, then we have a trend :)
No Doubt..tomorrow will be green again!
Stay away … red today
Biontech has started uptrend now and it will continue till 200 Euro
hope so
🚀Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccine-induced Antibodies Ability to Neutralize SARS-CoV-2 Omicron Variant. Pfizer and BioNTech have put into place a robust booster research program to help ensure that the vaccine continues to offer a high degree of protection. Moving forward, the companies will be evaluating the immunogenicity and efficacy of an additional dose of both the current formulation and an Omicron based vaccine in the clinical setting. The companies have previously announced that they expect to produce four billion doses of the Pfizer-BioNTech COVID-19 Vaccine in 2022, and this capacity is not expected to change if an adapted vaccine is required.🚀
with the appoach of UK to treat cobid like flu, other country will (hopefully) follow. This changes the revenue model. Around 1.5b flu shots / year worlwide, that would mean Pfizer BNTX has around 60% market, so around 900m dosis from 2023 onwards, meaning a new model would have revenues 3x (better 4x) lower. So revenue of aroudn 3.5b - I think it will go towards this valuation.
you are right! I don't understand why people are so panic. All retailer are selling stock but Instution are collecting. So definitely prise will go up soon.
Well my target is around 15b market cap, so half the price now (around 70). Will start to look at it again at that point. If not, other stocks are more interesting at this time.
you can buy and hold Biontech stock right perfect time. Hope it'll up from now. Targer 200 Euro
For long term yes maybe, short term clearly not when you see the NASDAQ and global market red everywhere since 2 weeks.
Right now -6 % and 138 $ . It was si obvious . Next target with global krach market (even the S&P 500 and NASDAQ are going down over and over) would be 90-100 $
Yes and then 10-15
Yes and then 10-15
This stock is about to surge like *****soon
hope not just in ur dream😅
vaccine company knows how to adapt to new variant quickly. please give them some credit that they know what they are doing. Some investors only know dollar and cents and nothing else. what a shame!!!
Borula Pfizer CEO said vaccination will be required every year, why don't the big investors look forward right now, I'm hodling till it was $380, price target by the end of the year $480. 💎🙌
This news is really not bullish for vaccine stock right now. It will be even worse for short term actually lol
because he said booster shot every 4-5 months is not effective and prefers 1 shot every year.
Probable new variant BA.2 under investigation by UK scientists.
rob roooooooooooo!
ok, I will stay with my short till 90-95 :-)
absolutely, but demand for vaccine is droping
look at Peloton - reducing production
which platform do you use for trade?
Still waiting for 90-95 $ to buy the dip ZzzzZZZ
Valneva +34 % in only 1 hour right now (between 19 or 20) after the studies with very good result against omicron.
+48 % now lool
+53 %  and in comparison you have.... Moderna and biontech lmao
Summer is coming - big threat for vaccine companies
 This company up so high only because of covid market (just like valneva) and not for other projects like cancer etc. Many people still don't understand this.
exactly
i mean because of covid so high
Never sell this stock, only buy more when it goes down. Huge mistake!
I already sold all my vax stocks. Sure will go up now. Good luck everybody!
‼️‼️OMICRON STORM ALL OVER THE WORLD JUST STARTING. Hospitals start to become full. Most probably new variants will come soon also. We need mRNA vaccines MUCH MORE THAN EVER. Forza Pfizer-BioNTech and Moderna🚀🚀🚀
simply BS
Africa and India do not need it
i want my moneybck
This is not a faulty device, it is the stockmarket buddy!
Be patient! wait a couple of months...maybe years :=)
imunity is virus called omicron- but new vacine only cleans the waves maybe
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.